Detail Information of Transcriptional Regulations

General Information of Drug Transporter (DT)
DT ID DTD0455 Transporter Info
Gene Name SLC6A3
Transporter Name Sodium-dependent dopamine transporter
Gene ID
6531
UniProt ID
Q01959

Transcriptional Regulation of This DT (TSR)

TF Superclass 1: Basic domains

      Class 1.2: Basic helix-loop-helix factors

Click to Show/Hide the Full List of 1 TF(s) Regulating This DT

        HEY1 

Click to Show/Hide to Show 2 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

 Repression of SLC6A3 gene in brain neuroblastoma condition [1]

TF Protein Name

 Hairy/enhancer-of-split related with YRPW motif protein 1 Transcription Factor Info

Studied Phenotype

 Brain neuroblastoma [ICD11: 2A00.11]

Tissue

 Brain

Related DT Changes

 Down regulating

Experimental Material

 Human neuroblastoma cells (SH-SY5Y)

Detailed Description

 Hairy/enhancer-of-split related with YRPW motif protein 1 (HEY1) has been reported to repress the transcription of SLC6A3 gene in brain neuroblastoma condition, which leads to a decreased expression of the drug transporter Sodium-dependent dopamine transporter.

       Transcriptional Phenomenon 2

 Repression of SLC6A3 gene in health condition [2]

TF Protein Name

 Hairy/enhancer-of-split related with YRPW motif protein 1 Transcription Factor Info

Studied Phenotype

 Heallth [ICD11: N.A]

Tissue

 Brain

Related DT Changes

 Down regulating

Experimental Material

 C57BL/6-129/Sv hybrid mice

Detailed Description

 Hairy/enhancer-of-split related with YRPW motif protein 1 (HEY1) has been reported to repress the transcription of SLC6A3 gene in health condition, which leads to a decreased expression of the drug transporter Sodium-dependent dopamine transporter.

TF Superclass 2: Zinc-coordinating DNA-binding domains

      Class 2.1: Nuclear receptors with C4 zinc fingers

Click to Show/Hide the Full List of 1 TF(s) Regulating This DT

        NR4A2 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

 Activation of SLC6A3 gene in health condition [3]

TF Protein Name

 Nuclear receptor subfamily 4 group A member 2 Transcription Factor Info

Affected Drug/Substrate

 Dopamine

Studied Phenotype

 Heallth [ICD11: N.A]

Tissue

 Brain

Related DT Changes

 Up regulating

Experimental Material

 E12.5 mice

Detailed Description

 Nuclear receptor subfamily 4 group A member 2 (NR4A2) has been reported to activate the transcription of SLC6A3 gene in health condition, which leads to an increased expression of the drug transporter Sodium-dependent dopamine transporter.

      Class 2.3: C2H2 zinc finger factors

Click to Show/Hide the Full List of 1 TF(s) Regulating This DT

        ZBTB14 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

 Activation of SLC6A3 gene in adrenal gland pheochromocytoma condition [4]

TF Protein Name

 Zinc finger and BTB domain-containing protein 14 Transcription Factor Info

Studied Phenotype

 Adrenal gland pheochromocytoma [ICD11: 2D11.1]

Tissue

 Adrenal gland

Related DT Changes

 Up regulating

Experimental Material

 Rat adrenal gland pheochromocytoma cells (PC12)

Detailed Description

 Zinc finger and BTB domain-containing protein 14 (ZBTB14) has been reported to activate the transcription of SLC6A3 gene in adrenal gland pheochromocytoma condition, which leads to an increased expression of the drug transporter Sodium-dependent dopamine transporter.

TF Superclass 3: Helix-turn-helix domains

      Class 3.1: Homeo domain factors

Click to Show/Hide the Full List of 2 TF(s) Regulating This DT

        OTP 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

 Activation of SLC6A3 gene in health condition [5]

TF Protein Name

 Homeobox protein orthopedia Transcription Factor Info

Studied Phenotype

 Heallth [ICD11: N.A]

Tissue

 Embryo

Related DT Changes

 Up regulating

Experimental Material

 Zebrafish

Detailed Description

 Homeobox protein orthopedia (OTP) has been reported to activate the transcription of SLC6A3 gene in health condition, which leads to an increased expression of the drug transporter Sodium-dependent dopamine transporter.

        PITX3 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

 Activation of SLC6A3 gene in health condition [6]

TF Protein Name

 Pituitary homeobox 3 Transcription Factor Info

Affected Drug/Substrate

 Dopamine

Studied Phenotype

 Heallth [ICD11: N.A]

Tissue

 Brain

Related DT Changes

 Up regulating

Experimental Material

 C57BL/6 Pitx3 KO mice

Detailed Description

 Pituitary homeobox 3 (PITX3) has been reported to activate the transcription of SLC6A3 gene in health condition, which leads to an increased expression of the drug transporter Sodium-dependent dopamine transporter.

TF Superclass 6: Immunoglobulin fold

      Class 6.2: STAT domain factors

Click to Show/Hide the Full List of 1 TF(s) Regulating This DT

        STAT6 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

 Activation of SLC6A3 gene in health condition [7]

TF Protein Name

 Signal transducer and activator of transcription 6 Transcription Factor Info

Studied Phenotype

 Heallth [ICD11: N.A]

Tissue

 Brain

Related DT Changes

 Up regulating

Experimental Material

 Sata6 KO mice

Detailed Description

 Signal transducer and activator of transcription 6 (STAT6) has been reported to activate the transcription of SLC6A3 gene in health condition, which leads to an increased expression of the drug transporter Sodium-dependent dopamine transporter.
References
1 Identification and characterization of the Hesr1/Hey1 as a candidate trans-acting factor on gene expression through the 3' non-coding polymorphic region of the human dopamine transporter (DAT1) gene. J Biochem. 2005 Feb;137(2):205-16.
2 Hesr1 knockout mice exhibit behavioral alterations through the dopaminergic nervous system. J Neurosci Res. 2006 Nov 15;84(7):1555-63.
3 Involvement of Nurr1 in specifying the neurotransmitter identity of ventral midbrain dopaminergic neurons. Eur J Neurosci. 2003 Oct;18(7):1731-8.
4 Human zinc finger protein 161, a novel transcriptional activator of the dopamine transporter. Biochem Biophys Res Commun. 2004 Jan 23;313(4):969-76.
5 Orthopedia homeodomain protein is essential for diencephalic dopaminergic neuron development. Curr Biol. 2007 May 15;17(10):873-80.
6 Vesicular monoamine transporter 2 and dopamine transporter are molecular targets of Pitx3 in the ventral midbrain dopamine neurons. J Neurochem. 2009 Dec;111(5):1202-12.
7 Down-regulation of dopamine transporter and abnormal behavior in STAT6-deficient mice. Int J Mol Med. 2005 May;15(5):819-25.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.